# Atlas Lithium Corp: financial statements, quarterly

ATLX · Nasdaq · CIK 1540684 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/atlx.md) · [Financials](/companies/atlx/financials.md) · [Filings](/companies/atlx/filings.md) · [Insiders](/companies/atlx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/atlx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [0.2](/filings/0001641172-25-009443.md) | [0.2](/filings/0001641172-25-021996.md) | [0.2](/filings/0001493152-25-022389.md) | [0.2 d](/filings/0001493152-26-038339.md) | [0.0](/filings/0001493152-26-021719.md) | [0.0](/filings/0001493152-26-038358.md) | [(0.0) d](/filings/0001493152-25-022389.md) | [0.0 d](/filings/0001493152-26-038339.md) | [0.1](/filings/0001493152-26-021719.md) | [0.0 d](/filings/0001493152-26-038358.md) |
| Cost of revenue | $m | not reported | not reported | [0.1](/filings/0001641172-25-009443.md) | [0.1](/filings/0001641172-25-021996.md) | [0.1](/filings/0001493152-25-022389.md) | [0.1 d](/filings/0001493152-26-038339.md) | [0.1](/filings/0001493152-26-021719.md) | [0.1](/filings/0001493152-26-038358.md) | [0.0 d](/filings/0001493152-25-022389.md) | [0.0 d](/filings/0001493152-26-038339.md) | [0.0](/filings/0001493152-26-021719.md) | [0.0 d](/filings/0001493152-26-038358.md) |
| Gross profit | $m | not reported | not reported | [0.1](/filings/0001641172-25-009443.md) | [0.1](/filings/0001641172-25-021996.md) | [0.1](/filings/0001493152-25-022389.md) | [0.0 d](/filings/0001493152-26-038339.md) | [(0.1)](/filings/0001493152-26-021719.md) | [(0.0)](/filings/0001493152-26-038358.md) | [0.0 d](/filings/0001493152-25-022389.md) | [0.0 d](/filings/0001493152-26-038339.md) | [0.1](/filings/0001493152-26-021719.md) | [0.0 d](/filings/0001493152-26-038358.md) |
| Operating income | $m | [(11.4)](/filings/0001493152-24-044315.md) | [(16.7) d](/filings/0001493152-25-010384.md) | [(13.2)](/filings/0001641172-25-009443.md) | [(9.5)](/filings/0001641172-25-021996.md) | [(10.3)](/filings/0001493152-25-022389.md) | [(10.9) d](/filings/0001493152-26-038339.md) | [(9.8)](/filings/0001493152-26-021719.md) | [(6.1)](/filings/0001493152-26-038358.md) | [(8.0)](/filings/0001493152-25-022389.md) | [(7.7) d](/filings/0001493152-26-038339.md) | [(16.8)](/filings/0001493152-26-021719.md) | [(11.8)](/filings/0001493152-26-038358.md) |
| Interest expense | $m | not reported | not reported | [0.2](/filings/0001641172-25-009443.md) | [0.2 d](/filings/0001641172-25-021996.md) | [0.2 d](/filings/0001493152-25-022389.md) | [0.2 d](/filings/0001493152-26-038339.md) | [0.2](/filings/0001493152-26-021719.md) | [0.2 d](/filings/0001493152-26-038358.md) | [0.2 d](/filings/0001493152-25-022389.md) | [0.2 d](/filings/0001493152-26-038339.md) | [0.2](/filings/0001493152-26-021719.md) | [0.2 d](/filings/0001493152-26-038358.md) |
| Income tax | $m | not reported | not reported | not reported | [0.0](/filings/0001641172-25-021996.md) | [0.0](/filings/0001493152-25-022389.md) | [0.0 d](/filings/0001493152-26-038339.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(11.3)](/filings/0001493152-24-044315.md) | [(16.4) d](/filings/0001493152-25-010384.md) | [(13.0)](/filings/0001641172-25-009443.md) | [(9.2)](/filings/0001641172-25-021996.md) | [(9.0)](/filings/0001493152-25-022389.md) | [(11.1) d](/filings/0001493152-26-038339.md) | [(9.0)](/filings/0001493152-26-021719.md) | [(5.6)](/filings/0001493152-26-038358.md) | [(7.0)](/filings/0001493152-25-022389.md) | [(6.6) d](/filings/0001493152-26-038339.md) | [(13.6)](/filings/0001493152-26-021719.md) | [(10.2)](/filings/0001493152-26-038358.md) |
| Diluted EPS | $ per share | [(1.24)](/filings/0001493152-24-044315.md) | not reported | [(1.02)](/filings/0001641172-25-009443.md) | [(0.67)](/filings/0001641172-25-021996.md) | [(0.60)](/filings/0001493152-25-022389.md) | not reported | [(0.55)](/filings/0001493152-26-021719.md) | [(0.31)](/filings/0001493152-26-038358.md) | [(0.35)](/filings/0001493152-25-022389.md) | not reported | [(0.50)](/filings/0001493152-26-021719.md) | [(0.35)](/filings/0001493152-26-038358.md) |
| Basic EPS | $ per share | [(1.24)](/filings/0001493152-24-044315.md) | not reported | [(1.02)](/filings/0001641172-25-009443.md) | [(0.67)](/filings/0001641172-25-021996.md) | [(0.60)](/filings/0001493152-25-022389.md) | not reported | [(0.55)](/filings/0001493152-26-021719.md) | [(0.31)](/filings/0001493152-26-038358.md) | [(0.35)](/filings/0001493152-25-022389.md) | not reported | [(0.50)](/filings/0001493152-26-021719.md) | [(0.35)](/filings/0001493152-26-038358.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [22.9](/filings/0001493152-23-037830.md) | [29.5](/filings/0001493152-25-010384.md) | [17.5](/filings/0001493152-24-044304.md) | [32.3](/filings/0001493152-24-044309.md) | [22.1](/filings/0001493152-24-044315.md) | [15.5](/filings/0001493152-26-038339.md) | [14.0](/filings/0001641172-25-009443.md) | [13.9](/filings/0001641172-25-021996.md) | [21.0](/filings/0001493152-25-022389.md) | [35.9](/filings/0001493152-26-038358.md) | [34.4](/filings/0001493152-26-021719.md) | [36.1](/filings/0001493152-26-038358.md) |
| Current assets | $m | [22.9](/filings/0001493152-23-037830.md) | [29.7](/filings/0001493152-25-010384.md) | [17.7](/filings/0001493152-24-044304.md) | [32.6](/filings/0001493152-24-044309.md) | [22.9](/filings/0001493152-24-044315.md) | [16.2](/filings/0001493152-26-038339.md) | [14.7](/filings/0001641172-25-009443.md) | [14.9](/filings/0001641172-25-021996.md) | [23.5](/filings/0001493152-25-022389.md) | [37.9](/filings/0001493152-26-038358.md) | [36.4](/filings/0001493152-26-021719.md) | [37.4](/filings/0001493152-26-038358.md) |
| Total assets | $m | [29.1](/filings/0001493152-23-037830.md) | [43.6](/filings/0001493152-25-010384.md) | [37.6](/filings/0001493152-24-044304.md) | [63.2](/filings/0001493152-24-044309.md) | [60.5](/filings/0001493152-24-044315.md) | [57.9](/filings/0001493152-26-038339.md) | [60.8](/filings/0001641172-25-009443.md) | [63.3](/filings/0001641172-25-021996.md) | [72.2](/filings/0001493152-25-022389.md) | [87.7](/filings/0001493152-26-038358.md) | [87.4](/filings/0001493152-26-021719.md) | [89.3](/filings/0001493152-26-038358.md) |
| Current liabilities | $m | [2.6](/filings/0001493152-23-037830.md) | [5.9](/filings/0001493152-25-010384.md) | [6.7](/filings/0001493152-24-044304.md) | [5.5](/filings/0001493152-24-044309.md) | [6.5](/filings/0001493152-24-044315.md) | [5.7](/filings/0001493152-26-038339.md) | [6.3](/filings/0001641172-25-009443.md) | [6.9](/filings/0001641172-25-021996.md) | [6.4](/filings/0001493152-25-022389.md) | [14.8](/filings/0001493152-26-038358.md) | [14.4](/filings/0001493152-26-021719.md) | [15.4](/filings/0001493152-26-038358.md) |
| Total liabilities | $m | [22.7](/filings/0001493152-23-037830.md) | [35.9](/filings/0001493152-25-010384.md) | [36.6](/filings/0001493152-24-044304.md) | [35.4](/filings/0001493152-24-044309.md) | [36.7](/filings/0001493152-24-044315.md) | [35.8](/filings/0001493152-26-038339.md) | [36.5](/filings/0001641172-25-009443.md) | [37.1](/filings/0001641172-25-021996.md) | [36.6](/filings/0001493152-25-022389.md) | [35.2](/filings/0001493152-26-038358.md) | [34.7](/filings/0001493152-26-021719.md) | [35.6](/filings/0001493152-26-038358.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [6.5](/filings/0001493152-23-037830.md) | [7.2](/filings/0001493152-25-010384.md) | [0.6](/filings/0001493152-24-044304.md) | [27.2](/filings/0001493152-24-044309.md) | [23.3](/filings/0001493152-24-044315.md) | [21.3](/filings/0001493152-26-038339.md) | [23.6](/filings/0001641172-25-009443.md) | [25.0](/filings/0001641172-25-021996.md) | [34.3](/filings/0001493152-25-022389.md) | [52.0](/filings/0001493152-26-038358.md) | [45.4](/filings/0001493152-26-021719.md) | [47.4](/filings/0001493152-26-038358.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(8.5) d](/filings/0001493152-24-044315.md) | [(8.5) d](/filings/0001493152-25-010384.md) | [(6.1)](/filings/0001641172-25-009443.md) | [(5.2) d](/filings/0001641172-25-021996.md) | [(2.9) d](/filings/0001493152-25-022389.md) | [(4.6) d](/filings/0001493152-26-038339.md) | [(4.4)](/filings/0001493152-26-021719.md) | [(3.9) d](/filings/0001493152-26-038358.md) | [(7.1) d](/filings/0001493152-25-022389.md) | [(6.8) d](/filings/0001493152-26-038339.md) | [(10.6)](/filings/0001493152-26-021719.md) | [(7.6) d](/filings/0001493152-26-038358.md) |
| Capital expenditure | $m | [(1.1) d](/filings/0001493152-24-044315.md) | [7.2 d](/filings/0001493152-25-010384.md) | [5.9](/filings/0001641172-25-009443.md) | [8.1 d](/filings/0001641172-25-021996.md) | [5.2 d](/filings/0001493152-25-022389.md) | [3.3 d](/filings/0001493152-26-038339.md) | [3.2](/filings/0001493152-26-021719.md) | [1.6 d](/filings/0001493152-26-038358.md) | [1.2 d](/filings/0001493152-25-022389.md) | [0.2 d](/filings/0001493152-26-038339.md) | [1.2](/filings/0001493152-26-021719.md) | [0.6 d](/filings/0001493152-26-038358.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [4.6](/filings/0001493152-23-037830.md) | [6.6](/filings/0001493152-24-044304.md) | [9.1](/filings/0001493152-24-030957.md) | [9.1](/filings/0001493152-24-044315.md) | [12.8](/filings/0001641172-25-009443.md) | [13.7](/filings/0001641172-25-021996.md) | [15.0](/filings/0001493152-25-022389.md) | [16.5](/filings/0001493152-26-021719.md) | [18.0](/filings/0001493152-26-038358.md) | [20.2](/filings/0001493152-25-022389.md) | [27.2](/filings/0001493152-26-021719.md) | [29.4](/filings/0001493152-26-038358.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 30,099,805 at 2026-08-10, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038358.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.